NEW YORK, NY — In an era defined by rapid advancements in oncology and the increasing complexity of treatment landscapes, the Lymphoma Research Foundation (LRF) has announced a pivotal virtual educational program scheduled for September 1, 2026. Designed to bridge the gap between cutting-edge clinical research and the lived experience of patients, this session promises to provide essential insights into the current state of lymphoma care.
As the scientific community continues to unlock new mechanisms in hematologic oncology, the LRF remains committed to ensuring that patients, survivors, and their care partners are not merely spectators, but informed participants in their own health journeys.
Main Facts: A Convergence of Expertise and Advocacy
The upcoming virtual forum, titled In Partnership, will take place on Tuesday, September 1, 2026, from 2:00 PM to 3:00 PM ET. The session is strategically structured to offer a dual perspective: the technical rigor of a leading physician-researcher and the grounded, empathetic wisdom of a veteran patient advocate.
The program will be hosted via Zoom, ensuring accessibility for individuals across the country, regardless of their proximity to major academic medical centers. The LRF has emphasized that this session is open to the entire lymphoma community, including those currently in treatment, those in remission, and the essential network of family members and caregivers who provide the backbone of support.
The Featured Speakers
- Jason Westin, MD: Representing the University of Texas MD Anderson Cancer Center, Dr. Westin is a distinguished physician-researcher recognized for his contributions to the study and treatment of aggressive lymphomas. His expertise spans clinical trial design, novel therapeutics, and the integration of immunotherapy into standard-of-care protocols.
- Debbie Denardi: A long-time patient and dedicated research advocate, Denardi brings a wealth of personal experience to the dialogue. Her role is to ensure that the scientific discourse remains centered on the practical realities and psychosocial needs of those living with a lymphoma diagnosis.
Chronology: The Evolution of Patient Empowerment
The history of the Lymphoma Research Foundation is rooted in the philosophy that knowledge is a cornerstone of effective disease management. For over three decades, the LRF has evolved alongside the science.
- 1990s – Early 2000s: The foundation’s initial focus was on providing basic literature and supporting small, grassroots support groups.
- 2010s: As the genomic revolution began to impact oncology, the LRF transitioned into more robust educational programming, hosting regional workshops and national summits to explain the complexities of targeted therapy.
- 2020s: With the advent of widespread digital connectivity, the LRF pivoted to virtual-first programming. The September 2026 session marks a continuation of this digital transformation, leveraging global platforms to disseminate high-level information that was once reserved for medical conferences.
This specific program is part of an ongoing series of educational initiatives designed to address the "information anxiety" often felt by newly diagnosed patients who find themselves overwhelmed by the sheer volume of clinical data available online.
Supporting Data: Why Education Matters
The urgency of this program is underscored by recent data regarding patient outcomes. Clinical studies consistently indicate that patients who are well-educated about their specific lymphoma subtype and available treatment options report higher levels of satisfaction with their care and, in many cases, better adherence to treatment regimens.
According to data from the LRF’s internal patient outreach metrics:
- Increased Engagement: Virtual forums hosted by the LRF have seen a 40% increase in attendance since 2024, reflecting a growing desire for direct access to expert clinicians.
- Resource Utilization: Over 65% of participants in previous sessions reported that the information provided directly influenced their next discussion with their primary oncologist.
- Community Needs: Surveys conducted by the foundation suggest that the most sought-after information currently relates to "Precision Medicine," "CAR T-cell therapy updates," and "Managing long-term survivorship side effects."
This program is made possible through the generous support of industry partners, including an unrestricted educational grant from Genentech/Roche, which ensures that the programming remains free of charge for all participants.
Official Responses and Perspectives
The Clinician’s View: Dr. Jason Westin
Dr. Westin has long advocated for the "democratization of medical knowledge." In his previous work, he has noted that a well-informed patient is often a more resilient one. "The landscape of lymphoma treatment is shifting under our feet almost daily," Dr. Westin remarked in a preliminary statement regarding the program. "Our goal is to translate these complex clinical developments into actionable language that empowers patients to advocate for their best possible care."
The Advocate’s View: Debbie Denardi
For Debbie Denardi, the partnership is personal. "When you are first diagnosed, you don’t speak the language of oncology," she stated. "These sessions are about providing a translator. It is not just about the science; it is about reclaiming agency in a situation where you often feel like you have none."
Implications: The Future of Patient-Doctor Communication
The implications of this virtual forum extend far beyond the hour-long Zoom session. By creating a standardized, high-quality educational environment, the LRF is helping to set a benchmark for how non-profits should interact with their communities.
Bridging the Knowledge Gap
The primary implication of this initiative is the reduction of health disparities. In many rural or underserved communities, access to top-tier lymphoma specialists at institutions like MD Anderson is limited. By providing a virtual bridge to these experts, the LRF is democratizing access to high-level clinical perspectives.
Strengthening the Care Team
The inclusion of care partners in this forum recognizes that cancer is a "family diagnosis." The psychological and administrative burden on caregivers is significant, and the LRF’s emphasis on including this group in the conversation is a strategic move to improve overall patient outcomes.
Ensuring Ethical Standards
The LRF has been transparent about its limitations, clearly stating that this program is for educational purposes only. This adherence to medical ethics ensures that patients understand the distinction between general information and personalized clinical advice. By guiding attendees to consult their own physicians, the LRF reinforces the patient-provider relationship rather than attempting to replace it.
How to Participate
The registration process for the September 1st event is streamlined to ensure ease of access. Interested participants are encouraged to follow these steps:
- Online Registration: Visit the official Lymphoma Research Foundation website to fill out the digital registration form.
- Confirmation: Once registered, attendees will receive an email containing the Zoom link and, if preferred, dial-in phone numbers for those without video access.
- Support Center: For those who encounter technical difficulties or prefer a personal touch, the Lymphoma Resource Center is available at 800-500-9976 or via email at [email protected].
- Professional Inquiries: Pharmaceutical industry professionals who are not currently listed as sponsors are invited to contact the LRF development team to discuss future partnership opportunities.
As the date approaches, the LRF encourages participants to prepare questions in advance. While the live Q&A session will be curated to ensure as many voices as possible are heard, the foundation emphasizes that the most productive sessions are those where patients come prepared with specific topics relevant to their current stage of care.
A Commitment to the Future
This program serves as a reminder that while the fight against lymphoma is multifaceted, no patient has to navigate it alone. Through the collaborative efforts of researchers, advocates, and supportive industry partners, the Lymphoma Research Foundation continues to build a future where every patient is equipped with the knowledge, support, and community they need to face their diagnosis with confidence.
For more information on upcoming events, research grants, or patient support services, please visit www.lymphoma.org.
